Boston, MA · Founded 2021 · Privately Held (backing)
Developer of a liquid biopsy platform designed to provide resolution into disease-defining biology from a blood test. Precede Biosciences is based in Boston, MA and was founded in 2021. Its last reported valuation was $199 million in Oct 2025. It has raised $132 million.
Last reported valuation
$198.5M
Oct 2026
Priced at
—
Total raised
$132.0M
Last round
—
Cap table — not yet on record
Precede Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Precede Biosciences with a free account
·The complete investor list: 17 names
·Watch Precede Biosciences: the Monday email on marks, rounds and moves
